Begin typing your search above and press return to search.

You Searched For "biotech insolvency"

Sec.12A IBC : Propriety Of Allowing Withdrawal Of CIRP At The Instance Of Defaulting Promoters

Sec.12A IBC : Propriety Of Allowing Withdrawal Of CIRP At The Instance Of Defaulting Promoters

The National Company Law Appellate Tribunal ('NCLAT') reversed the order of NCLT while adjudicating upon the matter concerning insolvency of Sterling Biotech. The NCLAT allowed the creditors to...

7 Oct 2019 7:09 AM GMT